Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 13127 | 795 | 45.3 | 93% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | LMO4 | Author keyword | 40 | 72% | 4% | 31 |
| 2 | LDB1 | Author keyword | 22 | 66% | 3% | 21 |
| 3 | LMO2 | Author keyword | 21 | 52% | 4% | 29 |
| 4 | TAL 1 | Author keyword | 19 | 76% | 2% | 13 |
| 5 | TAL1 | Author keyword | 12 | 44% | 3% | 20 |
| 6 | LYL1 | Author keyword | 12 | 86% | 1% | 6 |
| 7 | SCL TAL1 | Author keyword | 10 | 73% | 1% | 8 |
| 8 | SCL | Author keyword | 9 | 26% | 4% | 28 |
| 9 | LMO3 | Author keyword | 8 | 100% | 1% | 5 |
| 10 | LIM DOMAIN | Author keyword | 8 | 21% | 4% | 32 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | LMO4 | 40 | 72% | 4% | 31 | Search LMO4 | Search LMO4 |
| 2 | LDB1 | 22 | 66% | 3% | 21 | Search LDB1 | Search LDB1 |
| 3 | LMO2 | 21 | 52% | 4% | 29 | Search LMO2 | Search LMO2 |
| 4 | TAL 1 | 19 | 76% | 2% | 13 | Search TAL+1 | Search TAL+1 |
| 5 | TAL1 | 12 | 44% | 3% | 20 | Search TAL1 | Search TAL1 |
| 6 | LYL1 | 12 | 86% | 1% | 6 | Search LYL1 | Search LYL1 |
| 7 | SCL TAL1 | 10 | 73% | 1% | 8 | Search SCL+TAL1 | Search SCL+TAL1 |
| 8 | SCL | 9 | 26% | 4% | 28 | Search SCL | Search SCL |
| 9 | LMO3 | 8 | 100% | 1% | 5 | Search LMO3 | Search LMO3 |
| 10 | LIM DOMAIN | 8 | 21% | 4% | 32 | Search LIM+DOMAIN | Search LIM+DOMAIN |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | TRANSCRIPTION FACTOR SCL | 58 | 86% | 4% | 30 |
| 2 | SCL GENE | 57 | 59% | 8% | 65 |
| 3 | TAL 1 GENE | 52 | 76% | 5% | 37 |
| 4 | SCL GENE PRODUCT | 47 | 81% | 4% | 29 |
| 5 | PRIMITIVE MYELOID CELLS | 47 | 88% | 3% | 22 |
| 6 | LDB1 | 45 | 83% | 3% | 25 |
| 7 | SITE SPECIFIC DELETIONS | 44 | 85% | 3% | 23 |
| 8 | RBTN2 | 41 | 90% | 2% | 18 |
| 9 | SCL | 36 | 44% | 8% | 61 |
| 10 | LIM PROTEIN RBTN2 | 30 | 84% | 2% | 16 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| LIM-domain-only proteins in cancer | 2013 | 19 | 127 | 67% |
| The SCL gene: From case report to critical hematopoietic regulator | 1999 | 114 | 133 | 66% |
| LIM-domain-binding protein 1: a multifunctional cofactor that interacts with diverse proteins | 2003 | 82 | 38 | 79% |
| The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion | 2006 | 56 | 80 | 56% |
| Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency | 2004 | 146 | 82 | 43% |
| SCL: From the origin of hematopoiesis to stem cells and leukemia | 2004 | 88 | 201 | 56% |
| Functions of LIM-homeobox genes | 2000 | 255 | 72 | 24% |
| Breakpoint sites disclose the role of the V(D)J recombination machinery in the formation of T-cell receptor (TCR) and non-TCR associated aberrations in T-cell acute lymphoblastic leukemia | 2013 | 12 | 94 | 24% |
| Mechanisms of transcription factor deregulation in lymphoid cell transformation | 2007 | 78 | 166 | 20% |
| Transcriptional regulation of haematopoietic transcription factors | 2011 | 4 | 58 | 59% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SECT MAMMALIAN MOL GENET | 1 | 40% | 0.3% | 2 |
| 2 | ROTARY BONE MARROW S | 1 | 15% | 0.8% | 6 |
| 3 | ROTARY BONE MARROW | 1 | 16% | 0.6% | 5 |
| 4 | HEMOPOIESIS LEUKEMIA | 1 | 33% | 0.3% | 2 |
| 5 | STROKE RECOVERY | 1 | 11% | 0.9% | 7 |
| 6 | BALVATNIK COMP SCI | 1 | 50% | 0.1% | 1 |
| 7 | CLIN SCIADV TECHNOL | 1 | 50% | 0.1% | 1 |
| 8 | HAEMATOL ONCOL SCI SERAGNOLI | 1 | 50% | 0.1% | 1 |
| 9 | HAEMATOL PROGRAM | 1 | 50% | 0.1% | 1 |
| 10 | INSERM 434 | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000237761 | FHL2//REDUCING BODY MYOPATHY//FHL1 |
| 2 | 0.0000204924 | HOX11//TLX 1//PRH |
| 3 | 0.0000181685 | GATA 1//GATA 2//EDAG |
| 4 | 0.0000134792 | HEMANGIOBLAST//HEMOGENIC ENDOTHELIUM//AORTA GONAD MESONEPHROS |
| 5 | 0.0000112086 | DRS GENE//HEPATIC LEUKEMIA FACTOR//E2A HLF |
| 6 | 0.0000101669 | GFI1B//GFI1//ZELLBIOL TUMORFOR |
| 7 | 0.0000101239 | TEL AML1//LEUKAEMIA CYTOGENET GRP//ETV6 |
| 8 | 0.0000075535 | PAX5//EXPT HEMATOPOIESIS UNIT//EBF |
| 9 | 0.0000070860 | ID 1//ID4//ID2 |
| 10 | 0.0000057573 | PU1//SPI 1 PU1//SFPI1 PU1 |